Dr. Scott Dindot is using an AS pig model to develop, test, and validate potential AS therapeutics and to characterize the AS pig. This testing gets us another step closer to robust preclinical phase testing of potential therapeutics for Angelman syndrome and evaluation of novel behavior changes seen in this large animal model.